New and Practical Synthesis of N-(3-Cyano-7-ethoxy-4-oxo-1, 4-dihydroquinolin-6-yl)acetamide | |
Ma, Wenpeng3; Mao, Yongjun2; Xie, Kai1; Zhu, Qifeng1; Zhang, Rongxia2; Shen, Jingshan2; Sun, Hongbin3 | |
刊名 | JOURNAL OF HETEROCYCLIC CHEMISTRY |
2014-05 | |
卷号 | 51期号:3页码:866-868 |
ISSN号 | 0022-152X |
DOI | 10.1002/jhet.1901 |
文献子类 | Article |
英文摘要 | New and practical synthetic route of N-(3-cyano-7-ethoxy-4-oxo-1,4-dihydroquinolin-6-yl)acetamide (1) is described, through the cyclization of 2-aminophenyl-ethanone (12) with N,N-dimethylformamide dimethylacetal. The overall yield of 1 obtained from this process is 46% (five steps) with a purity of >99% (HPLC). |
资助项目 | National Science and Technology Major Project[2012ZX09301001-001] ; Key Project of Science and Technology of Shanghai[10431902800] |
WOS关键词 | ADDITION-ELIMINATION REACTION ; KINASE-ACTIVITY ; INHIBITORS ; OPTIMIZATION ; DERIVATIVES ; DISCOVERY ; SUBSTRATE ; AGENTS ; HER-2 ; EGFR |
WOS研究方向 | Chemistry |
语种 | 英语 |
出版者 | WILEY-BLACKWELL |
WOS记录号 | WOS:000337560000050 |
内容类型 | 期刊论文 |
源URL | [http://119.78.100.183/handle/2S10ELR8/277086] |
专题 | 成果转移转化处 药物化学研究室 |
通讯作者 | Sun, Hongbin |
作者单位 | 1.Topharman Shanghai Co Ltd, Shanghai 201209, Peoples R China 2.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; 3.China Pharmaceut Univ, Nanjing 210009, Jiangsu, Peoples R China; |
推荐引用方式 GB/T 7714 | Ma, Wenpeng,Mao, Yongjun,Xie, Kai,et al. New and Practical Synthesis of N-(3-Cyano-7-ethoxy-4-oxo-1, 4-dihydroquinolin-6-yl)acetamide[J]. JOURNAL OF HETEROCYCLIC CHEMISTRY,2014,51(3):866-868. |
APA | Ma, Wenpeng.,Mao, Yongjun.,Xie, Kai.,Zhu, Qifeng.,Zhang, Rongxia.,...&Sun, Hongbin.(2014).New and Practical Synthesis of N-(3-Cyano-7-ethoxy-4-oxo-1, 4-dihydroquinolin-6-yl)acetamide.JOURNAL OF HETEROCYCLIC CHEMISTRY,51(3),866-868. |
MLA | Ma, Wenpeng,et al."New and Practical Synthesis of N-(3-Cyano-7-ethoxy-4-oxo-1, 4-dihydroquinolin-6-yl)acetamide".JOURNAL OF HETEROCYCLIC CHEMISTRY 51.3(2014):866-868. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论